No definition available.
Hereditary deficiency of other clotting factors
DOID EFO Endpoint Browser PheWeb
D3_HEREDOTHCLOFACTORS
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
325 |
4. Check minimum number of eventsNone |
325 |
5. Include endpointsNone |
325 |
6. Filter based on genotype QC (FinnGen only) |
325 |
Control definitions (FinnGen only)
- Control exclude
- D3_COAGDEF_PURPUR_HAEMORRHAGIC
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D68
- Name in latin
- Deficientia hereditaria aliorum factorum coagulationis
Similar endpoints
↥List of similar endpoints to
Hereditary deficiency of other clotting factors
based on the number of shared cases.
Similar with more cases:
- Other coagulation defects
- Coagulation defects, purpura and other haemorrhagic conditions
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2150 | 1552 | 590 |
| Only index persons | 2039 | 1500 | 539 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.04 | 0.02 |
| Only index persons | 0.05 | 0.06 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 36.75 | 32.72 | 47.34 |
| Only index persons | 36.81 | 32.79 | 47.98 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 325 | 235 | 90 |
| Unadjusted period prevalence (%) | 0.07 | 0.08 | 0.04 |
| Median age at first event (years) | 42.72 | 37.12 | 57.34 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 292
- Matched controls
- 2918
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D68.2
ICD-10 Finland
Hereditary deficiency of other clotting factors
4503599627370496.0
323.0
287
*
D68.8
ICD-10 Finland
Other specified coagulation defects
+∞
117.9
105
*
B01AB05
ATC
enoxaparin; parenteral
7.1
51.9
175
505
B01AA03
ATC
warfarin; systemic
9.6
51.5
120
197
B01AB04
ATC
dalteparin; parenteral
17.1
40.0
65
48
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
16.3
32.9
54
40
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
60.2
32.1
37
7
D68.9
ICD-10 Finland
Coagulation defect, unspecified
+∞
21.1
20
*
D68.0
ICD-10 Finland
Von Willebrand disease
+∞
16.8
16
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
4.8
15.9
56
137
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
4.0
15.6
68
205
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
7.8
15.1
35
50
O28.0
ICD-10 Finland
Abnormal haematological finding on antenatal screening of mother
73.1
12.7
14
*
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
8.6
12.6
27
34
K94
ICPC
Phlebitis/thrombophlebitis
22.4
12.1
17
8
O99.4
ICD-10 Finland
Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium
17.9
11.3
17
10
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
9.7
10.7
21
23
D68.4
ICD-10 Finland
Acquired coagulation factor deficiency
+∞
9.4
9
*
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
12.0
9.2
16
14
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.2
8.8
129
782
I80.20
ICD-10 Finland
Phlebitis and thrombophlebitis in the iliac vein
51.5
8.7
10
*
N02AX02
ATC
tramadol; systemic, rectal
2.1
8.6
127
770
I82.9
ICD-10 Finland
Embolism and thrombosis of unspecified vein
9.9
8.4
16
17
R06.0
ICD-10 Finland
Dyspnoea
2.4
8.1
76
371
N02BE01
ATC
paracetamol; systemic, rectal
2.5
7.9
251
2075
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
7.7
90
486
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.6
7.5
33
100
I87.0
ICD-10 Finland
Postthrombotic syndrome
82.0
7.4
8
*
B01AB10
ATC
tinzaparin; parenteral
4.0
7.4
29
79
126
Kela drug reimbursment
Chronic coagulation defects
+∞
7.3
7
*
I80.9
ICD-10 Finland
Phlebitis and thrombophlebitis of unspecified site
16.2
7.3
11
7
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
4.9
7.1
22
48
I80.1
ICD-10 Finland
Phlebitis and thrombophlebitis of femoral vein
11.3
6.9
12
11
K99
ICPC
Cardiovascular disease other
8.4
6.4
13
16
M79.6
ICD-10 Finland
Pain in limb
1.9
6.2
113
722
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
6.0
6.2
16
28
I80.0
ICD-10 Finland
Phlebitis and thrombophlebitis of superficial vessels of lower extremities
4.9
6.2
19
41
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3036489) Thrombin time
72
88
10.23
57.07
6.9
2.7
s
23.4
21.9
0.69
60
77
(3018677) aPTT in Platelet poor plasma by Coagulation assay
115
311
5.18
41.44
5.7
2.1
s
34.6
29.8
1.66
109
306
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
154
581
4.14
35.01
4.4
1.8
mg/l
0.9
0.9
0.01
110
449
(3032080) INR in Blood by Coagulation assay
186
832
3.89
32.36
24.7
6.9
inr
1.6
1.1
5.44
58
271
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
42
55
8.62
30.91
6.9
3.5
u/ml
0.4
0.4
0.14
23
34
(3022217) INR in Platelet poor plasma by Coagulation assay
80
237
4.15
24.48
42.5
20.3
inr
1.8
1.2
—
6
39
(3033658) Prothrombin time (PT) actual/Normal
135
605
3.11
21.32
9.3
3.5
%
77.2
92.4
5.38
130
590
(42870588) Differential panel, method unspecified - Blood
152
825
2.58
15.56
7.0
5.8
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
171
1012
2.46
14.15
13.2
6.6
mmol/l
1.2
1.2
0.71
162
930
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
25
45
5.94
13.58
1.2
1.1
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
190
1218
2.35
12.61
7.1
5.5
%
0.7
0.7
0.07
179
1135
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
181
1141
2.32
12.44
9.8
7.1
mmol/l
1.2
1.2
0.35
156
985
(3022948) Iron [Moles/volume] in Serum or Plasma
83
369
2.68
12.38
4.2
2.4
umol/l
13.7
13.8
0.08
78
337
(3006504) Eosinophils/100 leukocytes in Blood
193
1254
2.33
12.30
7.0
5.4
%
2.6
2.8
0.84
180
1168
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
23
42
5.82
12.30
1.5
1.3
u/ml
1.9
6.1
—
7
15
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
73
307
2.78
12.11
4.6
2.4
%
23.5
23.3
0.05
65
269
(3019069) Monocytes/100 leukocytes in Blood
193
1261
2.31
12.04
7.1
5.7
%
8.2
8.1
0.19
182
1185
(3006315) Basophils [#/volume] in Blood
201
1349
2.28
11.58
7.1
5.5
e9/l
0.0
0.0
0.60
176
1180
(3024561) Albumin [Mass/volume] in Serum or Plasma
161
996
2.22
11.22
7.5
4.7
g/l
36.3
36.4
0.09
150
937
(3013115) Eosinophils [#/volume] in Blood
204
1392
2.25
11.09
7.4
5.9
e9/l
0.2
0.2
0.37
180
1245
(3001604) Monocytes [#/volume] in Blood
199
1346
2.23
11.03
7.2
5.4
e9/l
0.6
0.5
0.18
174
1179
(4306422)
21
40
5.54
10.73
1.3
1.1
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
193
1303
2.18
10.57
7.2
5.5
%
28.0
28.9
0.63
181
1223
(3018010) Neutrophils/100 leukocytes in Blood
191
1288
2.17
10.45
7.1
5.4
%
57.5
57.0
0.28
181
1209
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
22
45
5.17
10.42
1.5
1.2
u/ml
3.5
5.2
—
10
19
(3019198) Lymphocytes [#/volume] in Blood
200
1392
2.14
9.84
7.3
5.4
e9/l
1.9
2.0
0.46
174
1249
(3037522) Nuclear Ab [Titer] in Serum
80
391
2.39
9.55
1.5
1.3
titre
1349.1
448.5
0.80
11
85
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
255
1969
2.37
9.46
8.7
6.7
u/l
73.3
76.5
0.53
241
1847
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
106
587
2.20
9.40
3.3
2.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
109
613
2.17
9.28
3.3
2.0
mg/l
2.6
2.8
0.65
91
537
(3013826) Glucose [Moles/volume] in Serum or Plasma
198
1403
2.05
8.92
8.5
4.6
mmol/l
6.4
6.5
0.08
193
1290
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
51
211
2.68
8.59
3.7
4.2
u/l
220.3
234.3
0.60
46
205
(3018418) pH of Serum or Plasma
115
677
2.08
8.58
6.0
4.1
ph
7.4
7.4
0.06
28
116
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
49
199
2.72
8.55
2.9
2.5
ml/min/173m2
77.4
71.0
0.64
31
77
(3044640) Blood type and Crossmatch panel - Blood
129
796
2.03
8.44
3.7
2.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
78
410
2.19
7.71
4.0
3.2
ng/l
298.6
166.8
0.37
59
269
(3013650) Neutrophils [#/volume] in Blood by Automated count
210
1567
1.96
7.62
9.0
8.5
e9/l
4.2
4.0
0.37
192
1375
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
179
1273
1.90
7.44
6.6
5.8
umol/l
10.1
10.9
0.55
171
1216
(4268621)
15
31
5.02
7.00
3.1
2.1
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
53
249
2.35
6.79
15.7
6.8
mmol/l
105.3
104.4
1.21
53
239
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
135
903
1.85
6.57
3.8
3.2
u/l
26.2
30.6
1.92
129
871
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
6
0
+∞
6.27
1.0
0.0
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
47
218
2.35
6.19
3.1
3.0
%
1.7
1.7
0.09
42
198
(3002179) Metamyelocytes/100 leukocytes in Blood
41
181
2.45
6.01
4.2
3.4
%
0.3
0.4
—
6
29
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
10
16
6.42
5.99
1.2
1.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
163
1187
1.75
5.74
13.7
8.2
e9/l
0.0
0.0
0.32
134
964
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
73
417
1.97
5.65
4.0
2.6
mmol/l
2.4
2.4
3.62
68
363
(3023520) Reticulocytes [#/volume] in Blood
35
148
2.53
5.62
2.3
2.9
e9/l
72.5
68.9
0.25
25
116
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
9
7
13.17
5.61
1.1
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
25
89
2.96
5.54
15.4
16.8
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
41
189
2.34
5.47
4.8
3.5
%
0.0
0.2
—
7
43
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
12
26
4.75
5.30
1.1
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
39
179
2.34
5.25
5.0
3.6
%
0.0
0.0
—
6
35
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
164
1219
1.70
5.19
5.0
3.9
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
177
1343
1.70
5.19
4.5
2.8
ug/l
93.3
89.9
0.13
165
1262
(3017181) Myelocytes/100 leukocytes in Blood
42
201
2.25
5.14
4.7
3.5
%
0.4
1.0
—
8
50
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
12
27
4.58
5.08
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
12
27
4.58
5.08
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
12
27
4.58
5.08
1.1
1.1
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
10
19
5.40
5.07
2.0
2.1
e6/l
850.2
839.8
—
5
6
(3007853) Bacteria identified in Skin by Aerobe culture
55
295
2.04
5.05
2.1
1.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
101
665
1.75
4.92
6.8
6.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
25
96
2.74
4.85
1.3
1.9
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
120
833
1.70
4.81
3.6
3.0
mmol/l
2.3
2.3
2.37
105
746
(3013707) Erythrocyte sedimentation rate by Westergren method
238
1983
1.75
4.71
5.3
3.8
mm/h
10.7
10.2
0.24
228
1852
(3011412) CD3 cells [#/volume] in Blood
11
25
4.52
4.60
1.9
2.4
e9/l
1.0
1.3
—
5
14
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
8
8
10.21
4.54
1.1
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
30
131
2.42
4.52
3.6
2.8
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
11
26
4.34
4.39
1.1
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
11
26
4.34
4.39
1.1
1.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
297
2674
2.28
4.38
22.6
12.5
mmol/l
139.7
139.6
0.30
291
2608
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
85
551
1.73
4.31
2.9
3.3
ng/l
1431.2
1130.3
0.33
63
462
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
61
360
1.85
4.22
3.4
2.5
e6/l
4.4
2.5
0.72
32
189
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
119
848
1.64
4.21
3.5
3.3
ng/l
19.5
30.1
1.57
65
483
(3023103) Potassium [Moles/volume] in Serum or Plasma
297
2685
2.23
4.15
22.2
12.6
mmol/l
3.9
3.9
0.08
291
2611
(3000991) Gas panel - Venous blood
36
177
2.16
4.14
14.3
8.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
147
1110
1.59
4.06
2.1
2.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
125
912
1.60
3.97
2.3
1.8
pmol/l
98.0
96.1
0.18
82
491
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
43
230
2.00
3.97
1.9
1.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
80
521
1.71
3.96
1.3
1.2
iu/ml
31.4
30.5
0.02
23
171
(3022145) Colonoscopy Study observation
50
283
1.91
3.93
1.4
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
10
24
4.27
3.91
1.0
1.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
77
2.70
3.88
3.2
1.8
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
119
867
1.59
3.77
4.7
3.2
e6/l
45.9
82.0
0.45
87
594
(3002582) Erythrocytes [#/volume] in Urine
103
727
1.61
3.71
4.0
2.8
e6/l
16.6
138.8
0.74
83
546
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
106
754
1.60
3.70
2.3
2.5
u/l
53.6
53.6
0.00
101
714
(3003396) Base excess in Arterial blood by calculation
40
214
1.99
3.69
19.3
10.4
mmol/l
1.3
1.4
0.10
33
163
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
42
231
1.94
3.59
1.9
1.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
58
354
1.78
3.58
1.9
1.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
25
112
2.33
3.58
1.8
1.6
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
13
41
3.26
3.53
6.0
2.4
%
16.9
15.8
—
8
21
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
15
52
2.98
3.51
1.5
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
14
47
3.07
3.45
1.5
1.2
u/ml
318.6
157.5
—
9
28
(3019225) pH of Specimen
38
205
1.97
3.43
2.4
4.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
276
2475
1.76
3.35
17.8
10.2
ml/min/173m2
86.9
87.7
0.25
242
1997
(3023368) Bacteria identified in Blood by Culture
81
554
1.62
3.28
6.4
4.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
93
661
1.57
3.20
4.0
2.6
e6/l
0.3
0.3
0.04
74
482
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
60
382
1.70
3.19
3.4
2.4
e6/l
0.8
0.9
0.32
31
211
(3007164) IgA [Mass/volume] in Serum or Plasma
89
627
1.58
3.18
2.0
1.4
g/l
2.5
2.2
0.59
57
385
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
297
2734
2.00
3.16
20.1
11.4
mg/l
18.9
20.2
0.33
246
2099
(3042936) Bacteria identified in Isolate by Culture
54
335
1.73
3.15
2.8
2.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
39
219
1.89
3.14
3.6
3.0
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
140
1091
1.50
3.14
3.0
2.4
nmol/l
74.6
74.4
0.03
130
997
(36304419) Bacteria [Presence] in Urine
92
656
1.56
3.11
3.8
2.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
17
68
2.58
3.09
1.7
1.4
ug/g
338.3
322.1
0.09
11
40
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
114
855
1.51
3.05
4.3
2.9
—
—
—
0
0
(3012544) pH of Venous blood
38
214
1.88
3.04
5.2
3.9
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
15
57
2.71
3.01
1.5
1.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
92
661
1.55
3.00
1.7
1.7
mmol/l
1.4
1.4
0.26
79
573
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
32
171
1.97
2.98
2.0
2.1
u/l
1591.4
3503.7
0.57
14
67
(3037467) Urinalysis macro (dipstick) panel - Urine
213
1819
1.50
2.96
4.4
3.7
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
10
30
3.41
2.93
1.3
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
77
534
1.58
2.92
1.7
1.5
nmol/l
21.2
22.3
0.22
66
463
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
15
59
2.62
2.83
1.9
2.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
39
227
1.82
2.82
4.4
3.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
72
497
1.58
2.78
2.9
2.3
e6/l
4.8
8.0
0.96
61
432
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
6
8.44
2.76
2.8
2.2
—
—
—
0
0
(3026782) Osmolality of Urine
68
464
1.59
2.75
3.0
2.4
mosm/kgh2o
524.6
564.5
0.78
59
390
(3029075) Extractable nuclear Ab panel - Serum
7
14
5.08
2.74
1.1
1.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
7
14
5.08
2.74
1.3
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
6
10
6.09
2.71
1.2
1.3
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
17
73
2.40
2.70
14.2
5.9
kpa
8.3
8.5
0.17
17
68
(21494755) Public health laboratory ask at order entry panel
18
362
0.47
2.61
1.4
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
72
504
1.55
2.61
1.3
1.2
u/ml
24.4
7.5
0.61
26
212
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
304
2850
2.03
2.61
13.4
9.0
u/l
24.4
25.6
0.92
297
2773
(3019309) Folate [Moles/volume] in Red Blood Cells
57
378
1.62
2.59
1.7
1.7
nmol/l
1248.0
1168.5
0.23
44
287
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
21
102
2.13
2.53
17.4
10.7
mmol/l
24.7
24.5
0.12
21
94
(3048929) Epstein Barr virus Ab [Presence] in Serum
21
102
2.13
2.53
1.5
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
51
332
1.64
2.50
1.4
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
9
26
3.53
2.50
1.8
1.3
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
9
27
3.40
2.41
8.0
18.7
mmol/l
6.7
6.5
—
9
20
(40761511) CBC panel - Blood by Automated count
305
2875
1.99
2.37
19.1
10.8
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
12
47
2.61
2.29
1.3
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
12
47
2.61
2.29
1.3
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
49
323
1.61
2.29
1.4
1.2
—
—
—
0
0
(4010399)
28
158
1.84
2.26
1.4
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
10
36
2.83
2.22
7.7
6.1
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
5
9
5.62
2.22
2.6
1.8
ug/l
39.6
67.7
—
5
9
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
14
4.34
2.16
1.0
1.0
—
—
—
0
0
(3013512) EKG study
83
622
1.45
2.15
3.1
3.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
16
75
2.19
2.12
5.4
3.5
g/l
0.2
0.2
—
7
30
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
44
288
1.61
2.12
3.9
2.6
umol/l
8.7
7.2
0.17
38
250
(3026493) Urate [Moles/volume] in Serum or Plasma
81
606
1.45
2.11
3.0
2.5
umol/l
339.2
5143.7
1.95
72
547
(3009508) Creatinine [Moles/volume] in Urine
91
696
1.43
2.11
3.7
2.9
mmol/l
7.7
7.9
0.17
77
590
(3022806) Fractional oxyhemoglobin in Capillary blood
8
25
3.25
2.11
4.4
1.7
%
90.5
91.3
—
8
25
(40768443) Skin Pathology biopsy report
19
96
2.04
2.10
1.3
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
20
3.55
2.06
1.1
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
88
672
1.42
2.05
2.1
1.8
—
—
—
0
0
(1616796) Gas panel - Central venous blood
12
50
2.45
2.05
10.8
2.4
—
—
—
0
0
(4027681)
6
15
4.05
2.05
1.2
1.1
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
34
210
1.69
2.04
5.1
3.6
kpa
6.3
5.7
2.25
34
202
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
17
84
2.08
1.99
1.8
1.8
iu/l
3.0
5.5
—
8
28
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
7
21
3.38
1.97
1.6
1.5
pg
33.6
32.4
—
7
21
(3020779) Urea [Moles/volume] in Serum or Plasma
30
181
1.72
1.96
17.9
8.5
mmol/l
8.5
8.5
0.01
30
171
(3024928) Oxygen saturation in Venous blood
11
45
2.50
1.95
4.5
6.3
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
30
182
1.71
1.93
4.8
3.3
kpa
3.9
4.7
2.51
30
176
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
31
190
1.70
1.92
1.3
1.3
—
55.0
—
0
9
(3007461) Platelets [#/volume] in Blood
316
3054
2.25
1.91
29.6
17.1
e9/l
254.5
258.9
0.54
311
2998
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
233
2099
1.39
1.91
3.9
3.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
153
1293
1.35
1.90
3.7
3.1
estimate
0.0
0.0
0.00
41
260
(3042631) Mycobacterium sp identified in Specimen
7
22
3.23
1.89
1.3
4.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
51
356
1.51
1.87
1.7
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
11
46
2.44
1.87
1.1
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
196
1722
1.35
1.86
3.7
3.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
10
40
2.55
1.85
5.1
3.1
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
10
40
2.55
1.85
1.6
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
28
170
1.71
1.80
1.3
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
41
275
1.56
1.80
4.5
4.2
%
31.5
32.0
0.09
31
193
(3010813) Leukocytes [#/volume] in Blood
316
3057
2.22
1.79
29.6
17.1
e9/l
6.9
6.7
0.70
310
2989
(3026361) Erythrocytes [#/volume] in Blood
316
3056
2.23
1.79
29.6
17.1
e12/l
4.5
4.5
0.42
310
2993
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
25
148
1.75
1.76
1.8
1.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
12
54
2.27
1.76
1.8
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
9
36
2.54
1.75
1.6
1.4
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
19
3.20
1.67
1.0
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
21
121
1.79
1.62
18.8
8.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
275
2573
1.45
1.62
21.2
12.5
%
39.8
40.1
0.31
219
2055
(3021788) Differential panel - Synovial fluid
8
32
2.54
1.60
1.0
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
26
2.73
1.59
1.1
1.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
20
3.04
1.59
1.2
2.6
—
—
—
0
0
(4035726)
32
209
1.59
1.58
1.3
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
151
1298
1.31
1.58
5.1
4.3
estimate
0.0
0.0
0.50
44
259
(3009261) Glucose [Presence] in Urine by Test strip
152
1308
1.30
1.58
3.9
3.2
estimate
0.0
0.0
0.50
40
251
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
234
2140
1.33
1.53
5.2
4.1
pmol/l
14.6
14.5
0.50
218
1986
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
32
211
1.57
1.53
2.3
2.3
—
18.6
—
0
12
(3020717) Zinc [Moles/volume] in Serum or Plasma
5
15
3.37
1.53
5.8
1.1
umol/l
11.7
24.2
—
5
15
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
25
155
1.66
1.52
10.5
4.7
mmol/l
1.6
1.3
0.42
18
120
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
28
2.53
1.46
1.1
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
26
165
1.63
1.45
1.2
1.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
10
46
2.21
1.41
2.0
3.6
e9/l
3.9
4.3
—
10
46
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
10
46
2.21
1.41
2.4
3.8
%
60.8
57.1
—
10
46
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
9
40
2.28
1.41
1.4
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
29
2.44
1.40
1.1
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
29
2.44
1.40
1.0
1.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
29
2.44
1.40
1.1
1.3
—
—
—
0
0
(4062490)
7
29
2.44
1.40
1.3
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
29
2.44
1.40
1.1
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
29
2.44
1.40
1.1
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
29
2.44
1.40
1.1
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
89
722
1.32
1.40
2.8
2.5
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
52
388
1.41
1.38
2.3
2.3
ug/g
90.8
109.9
0.37
41
306
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
9
41
2.23
1.38
1.0
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
9
41
2.23
1.38
2.1
1.4
—
—
—
0
0
(3009343) pH of Capillary blood
25
160
1.61
1.36
10.5
4.6
ph
7.4
7.4
—
6
14
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
10
47
2.16
1.35
1.3
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
11
54
2.07
1.34
2.5
1.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
20
121
1.70
1.34
1.7
1.6
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
24
2.53
1.31
3.7
3.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
24
2.53
1.31
1.3
3.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
25
162
1.59
1.30
10.5
4.6
kpa
5.3
5.1
0.95
25
154
(3019230) Fractional oxyhemoglobin in Venous blood
8
36
2.25
1.25
5.0
5.8
%
60.3
64.0
—
8
36
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
8
36
2.25
1.25
1.1
1.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
268
2526
1.35
1.24
6.1
4.7
mu/l
1.8
1.8
0.02
247
2361
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
86
706
1.30
1.23
1.5
1.3
u/ml
0.6
1.4
1.97
25
197
(3015183) Erythrocyte sedimentation rate
5
19
2.66
1.22
1.0
1.1
—
—
—
0
0
(44790048)
6
26
2.33
1.19
1.3
1.5
—
—
—
0
0
(44806118)
6
26
2.33
1.19
1.3
1.5
—
—
—
0
0
(44790049)
6
26
2.33
1.19
1.3
1.5
—
—
—
0
0
(44790047)
6
26
2.33
1.19
1.3
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
41
302
1.41
1.18
1.3
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
84
692
1.29
1.17
4.5
3.3
estimate
0.0
0.0
0.80
42
254
(40760892) CBC W Ordered Manual Differential panel - Blood
82
674
1.29
1.16
5.5
4.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
91
760
1.27
1.14
3.6
2.8
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
30
210
1.47
1.13
1.3
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
8
40
2.02
1.13
1.0
1.9
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
68
549
1.30
1.10
1.8
1.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
12
66
1.85
1.10
2.7
2.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
25
170
1.51
1.08
1.0
1.0
—
—
—
0
0
(4094501)
12
67
1.82
1.06
1.0
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
30
214
1.44
1.04
3.3
4.1
ug/l
2.4
8.5
1.72
20
168
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
22
2.29
1.03
1.0
1.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
22
2.29
1.03
1.4
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
47
1.94
1.03
1.0
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
10
53
1.91
1.02
1.2
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
51
400
1.33
1.02
1.8
1.7
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
35
2.02
1.00
1.1
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
20
132
1.55
0.99
1.9
1.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
49
1.86
0.99
1.0
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
27
2.24
0.94
1.0
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
72
599
1.26
0.93
4.1
3.2
mg/l
83.0
290.3
0.71
51
400
(3044290) Cell count panel - Cerebral spinal fluid
10
55
1.84
0.93
1.2
1.7
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
6
28
2.16
0.92
1.8
2.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
6
29
2.09
0.89
1.0
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
75
630
1.25
0.89
5.9
3.9
mg/mmol
12.9
10.5
0.17
56
403
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
10
56
1.81
0.88
1.2
1.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
201
1864
1.21
0.88
4.6
2.9
u/l
44.3
39.1
0.41
189
1779
(3004716) Salmonella sp identified in Stool by Organism specific culture
25
179
1.43
0.87
1.2
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
44
1.84
0.86
1.1
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
44
1.84
0.86
1.1
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
15
96
1.59
0.86
1.7
1.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
6
31
1.95
0.85
1.5
1.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
6
31
1.95
0.85
4.2
1.5
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
6
31
1.95
0.85
1.2
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
32
1.89
0.82
2.0
2.8
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
271
2598
1.26
0.80
4.9
3.9
mmol/l
4.6
4.7
1.29
253
2455
(3011397) Hemoglobin [Presence] in Urine by Test strip
68
572
1.24
0.80
3.4
3.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
34
261
1.34
0.80
1.3
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
33
1.83
0.79
1.0
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
33
1.83
0.79
1.2
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
18
123
1.49
0.79
1.4
1.3
miu/ml
331.0
243.1
0.47
11
64
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
34
1.78
0.76
2.5
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
5
24
2.10
0.75
2.0
3.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
25
2.02
0.73
1.0
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
261
2500
1.22
0.73
4.6
3.5
mmol/l
1.3
1.2
0.36
246
2347
(3015235) Bicarbonate [Moles/volume] in Capillary blood
10
60
1.69
0.73
5.5
3.4
mmol/l
24.4
23.6
—
10
52
(3016018) Differential panel - Cerebral spinal fluid
5
26
1.94
0.71
1.0
2.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
56
469
1.23
0.70
1.8
1.6
pmol/l
452.9
20146074.5
0.50
44
412
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
262
2517
1.21
0.67
4.4
3.9
mmol/l
5.8
5.8
0.09
241
2339
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
28
1.80
0.66
1.2
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
15
103
1.48
0.66
3.3
2.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
23
301
0.75
0.64
2.2
1.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
268
2583
1.21
0.64
5.0
3.9
mmol/l
1.4
1.5
1.98
252
2432
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
5
29
1.74
0.64
2.0
1.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
273
2637
1.22
0.63
5.3
4.3
mmol/l
2.8
2.8
0.94
256
2476
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
49
1.65
0.62
9.3
2.7
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
44
364
1.24
0.62
1.6
1.8
%
1.6
1.4
0.54
37
331
(3011288) Drugs identified in Urine by Screen method
15
105
1.45
0.61
1.6
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
8
51
1.58
0.61
1.0
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
17
231
0.72
0.61
2.0
1.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
243
2328
1.17
0.59
6.1
5.0
mmol/mol
39.3
38.8
0.25
223
2204
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
57
492
1.19
0.54
2.3
2.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
9
135
0.66
0.53
1.3
1.4
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
10
67
1.51
0.50
2.4
1.5
u/l
15.2
23.5
—
10
54
(3020961) Endomysium IgA Ab [Titer] in Serum
23
181
1.29
0.49
1.3
1.1
titre
—
8.0
—
0
5
(3020891) Body temperature
11
76
1.46
0.48
29.4
4.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
47
1.50
0.48
1.3
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
16
120
1.35
0.47
15.0
5.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
7
48
1.47
0.47
1.7
1.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
41
349
1.20
0.46
1.9
1.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
111
1025
1.13
0.44
4.1
3.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
88
801
1.14
0.43
1.7
1.5
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
5
31
1.62
0.43
2.0
1.6
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
5
32
1.57
0.42
1.2
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
16
0.00
0.41
0.0
5.6
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
0
17
0.00
0.41
0.0
1.5
—
7.7
—
0
12
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
35
298
1.20
0.40
3.1
2.9
ug/l
0.7
0.8
0.20
22
200
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
18
0.00
0.40
0.0
3.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
61
1.32
0.40
1.5
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
8
61
1.32
0.40
2.8
3.6
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
12
89
1.36
0.38
1.2
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
12
89
1.36
0.38
1.2
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
18
143
1.27
0.37
1.0
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
37
1.36
0.37
1.0
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
9
70
1.29
0.37
2.0
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
9
70
1.29
0.37
2.0
1.3
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
5
76
0.65
0.36
3.6
1.4
nmol/l
0.1
0.4
—
5
62
(1002224) Polysomnography panel
18
144
1.26
0.36
1.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
12
91
1.33
0.34
1.2
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
46
1.31
0.33
1.3
1.5
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
28
239
1.19
0.32
1.1
1.4
iu/l
20.4
23.2
0.21
22
209
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
45
400
1.15
0.32
1.6
1.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
30
258
1.18
0.32
1.1
1.2
iu/ml
218.5
138.5
—
10
103
(3000492) Spirometry study
30
258
1.18
0.32
1.6
1.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
7
99
0.70
0.31
1.6
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
7
55
1.28
0.30
1.1
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
56
510
1.12
0.28
4.7
4.8
ug/l
1.4
2.6
1.19
46
460
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
11
140
0.78
0.28
1.5
1.7
mg/l
3.1
2.6
—
6
101
(3043409) Potassium [Moles/volume] in Arterial blood
8
62
1.30
0.28
38.6
4.0
mmol/l
3.8
3.9
—
8
53
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
16
131
1.23
0.27
1.9
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
11
86
1.29
0.26
1.3
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
26
295
0.87
0.23
1.7
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
18
210
0.85
0.22
1.7
1.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
5
40
1.25
0.22
1.2
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
14
116
1.22
0.22
2.3
1.9
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
19
220
0.86
0.22
1.7
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
5
42
1.19
0.21
1.8
1.7
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
8
101
0.79
0.21
1.9
1.7
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
8
103
0.77
0.21
1.5
1.5
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
12
0.00
0.21
0.0
6.9
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
10
122
0.81
0.19
2.0
1.6
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
58
1.21
0.18
1.4
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
11
91
1.22
0.18
1.1
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
101
1052
0.94
0.17
3.1
2.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
14
121
1.16
0.15
1.7
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
63
663
0.94
0.14
1.8
1.6
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
7
89
0.78
0.14
1.3
1.5
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
12
103
1.17
0.14
4.0
3.6
%
0.9
1.2
1.33
12
103
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
12
103
1.17
0.14
1.9
1.8
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
8
100
0.80
0.14
1.4
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
17
151
1.13
0.13
2.9
2.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
11
125
0.88
0.10
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
11
125
0.88
0.10
1.5
1.4
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
5
46
1.09
0.09
4.6
2.2
ug/min
157.6
216.3
—
5
26
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
47
1.06
0.09
1.4
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
56
1.07
0.08
1.2
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
56
1.07
0.08
1.2
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
12
107
1.13
0.08
2.2
1.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
5
60
0.83
0.08
2.0
1.5
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
7
64
1.10
0.08
1.3
1.6
mmol/l
3.2
3.6
—
7
58
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
14
127
1.11
0.08
1.1
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
7
84
0.83
0.07
1.3
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
84
1.07
0.07
1.3
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
9
100
0.90
0.06
1.3
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
19
179
1.07
0.05
5.1
3.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
46
449
1.03
0.03
2.2
1.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
16
152
1.06
0.02
1.8
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
16
152
1.06
0.02
1.7
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
12
113
1.06
0.02
2.9
3.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
15
143
1.05
0.01
1.8
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
16
153
1.05
0.01
1.7
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
14
134
1.05
0.00
1.3
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
26
266
0.98
0.00
8.4
6.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
55
556
0.99
0.00
4.3
3.3
kg/l
1.0
1.0
—
6
66
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
10
97
1.03
0.00
1.6
1.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
10
97
1.03
0.00
1.4
1.8
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
15
153
0.98
0.00
1.4
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
15
153
0.98
0.00
1.8
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
41
407
1.01
0.00
4.2
4.3
%
25.9
21.4
0.47
15
194
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
63
627
1.01
0.00
1.7
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
12
125
0.96
0.00
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
12
125
0.96
0.00
1.4
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
23
234
0.98
0.00
1.4
1.5
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(44806420)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
3.3
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
57
0.88
0.00
1.8
1.8
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
6
0.00
0.00
0.0
1.2
—
1.5
—
0
6
(3032868) Hemoglobin electrophoresis panel in Blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
7
0.00
0.00
0.0
1.7
—
1.3
—
0
7
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
6.5
—
0
5
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
85
0.94
0.00
1.0
1.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint D3_HEREDOTHCLOFACTORS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_HEREDOTHCLOFACTORS | 1.209 [0.9, 1.63] | 0.215 |
| Birth year | 0.999 [0.99, 1.01] | 0.889 |
During the follow-up period (1.1.1998 — 31.12.2019), 51 out of 1392 females with D3_HEREDOTHCLOFACTORS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_HEREDOTHCLOFACTORS | 1.731 [1.28, 2.33] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.004 |
During the follow-up period (1.1.1998 — 31.12.2019), 64 out of 470 males with D3_HEREDOTHCLOFACTORS died.
Mortality risk
Mortality risk for people of age
years, who have D3_HEREDOTHCLOFACTORS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.131% | 0.313% |
| 5 | 0.801% | 2.019% |
| 10 | 2.02% | 4.984% |
| 15 | 3.777% | 8.99% |
| 20 | 6.841% | 15.016% |
Relationships between endpoints
↥Index endpoint: D3_HEREDOTHCLOFACTORS – Hereditary deficiency of other clotting factors
GWS hits: 13
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data